Feb 29, 2024 / NTS GMT
Presentation(Pre-recorded)
Feb 29, 2024 / NTS GMT
=====================
Corporate Participants
=====================
* Richard Fairman
CVS Group PLC - Chief Executive Officer, Director
* Robin Alfonso
CVS Group PLC - Chief Financial Officer, Director
* Ben Jacklin
CVS Group PLC - Deputy CEO
=====================
Conference Call Participants
=====================
* Delphine Holopherne-Doran
Bristol Vet Specialists - Clinical Director
=====================
Richard Fairman - CVS Group PLC - Chief Executive Officer, Director
Good morning, and welcome to our interim results presentation.
We are pleased to have delivered a strong set of results with CVS remaining on track to deliver against the ambitions, which we outlined in our November 2022 Capital Markets Day. We delivered revenue of GBP329.9 million in the first half, and this represents growth of 11.4% over the prior half year. Like-for-like revenue growth was 6%, remaining comfortably within our ambition of between 4% and 8% per
Half Year 2024 CVS Group PLC Earnings Presentation(Pre-recorded) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot